- Home
- GOVX vs GBR Comparison
GOVX vs GBR Comparison
Compare GOVX & GBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOVX | GBR |
|---|---|---|
| Founded | 2001 | 1978 |
| Country | United States | United States |
| Employees | 19 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 3.2M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | GOVX | GBR |
|---|---|---|
| Price | $0.80 | $0.70 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 201.0K | 43.1K |
| Earning Date | 04-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $155,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.16 |
| 52 Week Low | $0.12 | $0.62 |
| 52 Week High | $4.40 | $1.31 |
Technical Indicators
Market Signals| Indicator | GOVX | GBR |
|---|---|---|
| Relative Strength Index (RSI) | 40.83 | 50.19 |
| Support Level | $0.64 | $0.64 |
| Resistance Level | $2.00 | $0.75 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 42.26 | 51.96 |
Price Performance
Historical ComparisonAbout GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
About GBR New Concept Energy Inc
New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations.